CYP cynata therapeutics limited

Ann: Cynata to Acquire IP from Tekcyte, page-9

  1. 216 Posts.
    lightbulb Created with Sketch. 35
    "Expect a new licensee."

    likely by sounds of CEO comment "and simplifies our commercial proposition for potential partners."

    A deal based on pending results outcome (like Fuji), or just wait for the study report in 6-9 months?

    Agree with the bargain and shares better than cash and we have another commercial shareholder in Tekcyte.
    Tony Simula is a very experienced guy.
    I expect they see upside from their allocation at that price.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.5¢
Change
0.005(3.33%)
Mkt cap ! $35.02M
Open High Low Value Volume
15.5¢ 15.5¢ 15.5¢ $2.903K 18.72K

Buyers (Bids)

No. Vol. Price($)
6 230650 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 1500 1
View Market Depth
Last trade - 10.20am 17/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.